Debiopharm Research and Manufacturing S.A. (manufacturing, primary packaging, quality control and stability testing: powder)

The drug is used for the treatment of advanced or metastatic hormone-sensitive prostate cancer, as well as in combination with radiotherapy for high-risk localized cancer. It is also prescribed to children (girls up to 8 years of age and boys up to 10 years of age) for central precocious puberty.

Dosage form: powder and solvent for suspension for injection with prolonged release

ATC: L02AE04